Monday, August 31, 2026

SmileDirectClub Stock Jumps 18% In 5 Sessions: Is It Time To Invest?

ViaNews Editorial Team

September 18, 2023

SmileDirectClub Stock Jumps 18% In 5 Sessions: Is It Time To Invest?

(VIANEWS) - SmileDirectClub stock surges 18.56% over five sessions on the NASDAQ; up 0.16% overall. SmileDirectClub (NASDAQ: SDC) shares have seen an incredible spike over the last five sessions, increasing by 18-56% from EUR0.39 at 18.56 on May 18 to EUR0.46 by 14:09 EST on Monday afternoon. Even after last session's downward trend, the NASDAQ gained 0.16% to EUR13,730.74, maintaining its upward momentum. SmileDirectClub closed at EUR0.42, 68.19% below its 52-week high of EUR1.35. SmileDirectClub's recent surge may be attributable to either positive market sentiment or company news that has yet to be made public. Investors should keep tabs on news from SmileDirectClub and monitor financial performance closely in order to better understand why their stock is fluctuating so dramatically.

About SmileDirectClub

SmileDirectClub is an oral care company offering clear aligner therapy through their end-to-end process, including marketing, aligner manufacturing and fulfillment, remote clinical monitoring through SmileCheck teledentistry platform as well as remote clinical monitoring by marketing staff and staff on-site at its facilities in Nashville Tennessee as well as Puerto Rico Canada Australia New Zealand Ireland Hong Kong Germany Singapore France Spain Austria. They service customers globally including in United States Puerto Rico Canada Australia United Kingdom New Zealand Ireland Hong Kong Germany Singapore France Spain and Austria and also offers impression and whitening kits whitening gels retainers toothbrushes toothpastes water flossers as well as water flossers with SmileSpa devices to keep teeth at ease if needed during therapy treatments or visits based at SmileSpa for remote dental visits or similar products for use at their locations worldwide offices based at Nashville Tennessee location. They were established in 2014 with headquarters based out of Nashville Tennessee location.

Yearly Analysis

SmileDirectClub stock has experienced a substantial decrease since reaching its 52-week high of EUR1.35, yet remains higher than its 52-week low of EUR0.32 within one year. This suggests a notable decline in value. SmileDirectClub anticipates negative 6.3% sales growth this year and 11.3% next year; this indicates their revenue could decline this year before rebounding next year. SmileDirectClub currently boasts an EBITDA score of 2.19, providing an accurate measurement of its profitability by taking into account earnings, interest, taxes, depreciation and amortization expenses. A positive EBITDA indicates that profits are being generated and is in good financial condition. Before making investment decisions, investors are advised to closely examine current stock price, sales growth outlook and EBITDA figures before making decisions. Furthermore, it's advisable for them to conduct further research and analysis on company financial performance, industry trends and any other pertinent elements before reaching a verdict.

Technical Analysis

SmileDirectClub stock has seen its price decline significantly, falling well below both its 50-day and 200-day moving averages of EUR0.61 and EUR0.51. This indicates a downward trend; further support can be seen with today's reported volume being 68.11% lower than its average volume of 2212430 - further supporting such speculation. Examining the stock's volatility, we can see that its intraday variation average over the past week, month and quarter was positive 2.71%, negative 2.06% and positive 7.27%, respectively. Furthermore, its highest amplitude of average volatility for these same periods was 3.40% (last week), 5.30% (month) and 7.27% (quarter). These numbers demonstrate that while its volatility had previously been high it has since trended downhill. Additionally, according to the stochastic oscillator - an indicator that measures overbought and oversold conditions - the stock may soon experience a price rebound. Overall, SmileDirectClub stock is currently trending downward, as its value has dropped below its moving averages and reported volume has decreased considerably compared to average. Furthermore, volatility in its past has resulted in its current downward trend; however, currently oversold status could signal a potential price rebound within months.

Quarter Analysis

Based on the available information, here is an investment outlook for SmileDirectClub: Sales Growth: SmileDirectClub currently is experiencing sales growth of 10.4% for this quarter and 26.5% expected for next quarter - two indicators of positive short term expansion for investors. With revenue on an upward trajectory, these numbers provide further confirmation that this company's performance is positive for them as investors. Growth Estimates Quarters: Our company's estimated quarterly growth estimates for this quarter and next are 55.6% and 61.1% respectively, signalling to investors that its growth should continue in the short term; this bodes well. High growth estimates also signal expansion of operations and an increase in revenue - both are positive indicators for investors. Revenue Growth: Year-on-year quarterly revenue growth has declined by 19.1% for the twelve trailing months ending June 2018, reaching 414.88M for investors to consider. While this decrease may cause concern, it should be remembered that revenue is still growing at a slower pace. It could be caused by any number of factors including increased competition or changes in consumer behaviour; but company growth estimates predict an uptick soon enough which should reassure them. Overall, SmileDirectClub seems like an attractive investment prospect. Their sales growth and estimated revenue projections indicate expansion in operations as well as increasing revenue growth; although their year-on-year quarterly revenue growth may have decreased recently, its estimated future growth estimates show it should return shortly - however it should be remembered that past performance does not guarantee future outcomes and investors must do further research before making investment decisions.

Equity Analysis

Based on its trailing twelve month EPS of EUR-2.628, SmileDirectClub currently shows negative earnings - an indicator that its operations may not generate sufficient profit or dividends to shareholders. Financial instability and limited growth potential should always be red flags for potential investors, and negative earnings can serve as an early warning sign. Before making an investment decision, investors must also carefully consider other aspects such as revenue growth, market trends and management's plans for profitability. Furthermore, investors should review a company's financial statements such as their balance sheet and cash flow statement in order to gain a clearer picture of its financial health and potential growth.

More news about SmileDirectClub (SDC).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI's Trust Gap: Microsoft-Mistral Ecosystem Expansion Meets a Governance Deficit in Agentic Adoption
Microsoft is deepening its AI platform bet through simultaneous moves — expanding its Mistral partnership (Copilot Studio, Foundry, European infrastructure capacity) and deepening enterprise AI governance ties with Manulife — just as independent research (Google Cloud, VentureBeat, Box) shows enterprises racing toward agentic AI adoption (100% planned within two years) while data access and trust in agent decisions lag badly (average 45% data access, only ~half trust agent outputs). The result is a structural mismatch between platform-vendor momentum and enterprise readiness to actually govern and trust the agents being deployed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
Same entity (Morgan Stanley & Co. LLC), same metric (net_income), same fiscal period (Q1 2026), same observation date (2026-03-31), but vastly different values: $5.567 billion vs. $5.57. These cannot coexist for the same time period. Fact B appears to be a data entry error (possible missing decimal placement: 5.57 should likely be 5,567,000,000 or a per-share figure incorrectly entered as total).
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,257 source documents archived
Query this data → isubstrate.com